Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome
PEEP-Réa
Pulmonary and Ventilatory Effects of End-expiratory Positive Pressure Optimization in Intubated ICU Patients With Healthy Lungs or Acute Respiratory Distress Syndrome. A Randomized Controlled Trial
1 other identifier
interventional
45
1 country
1
Brief Summary
PEEP titration is a recommended during invasive mechanical ventilation of ICU patients. However, little is known about the right way to conduct this titration. PEEP titration can be conducted by a stepwise increase in PEEP level, or following an ARM and a consecutive stepwise decrease in PEEP level. Those 2 methods will be explored in intubated ICU patients either with healthy lung or ARDS lungs. Physiological exploration will include end-expiratory lung volume measurements, driving pressure, compliance and electro-impedance tomography at each PEEP level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2019
CompletedFirst Submitted
Initial submission to the registry
July 13, 2020
CompletedFirst Posted
Study publicly available on registry
August 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedAugust 25, 2021
August 1, 2021
2 years
July 13, 2020
August 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recruited lung volume at each PEEP level between the 2 strategies (incremental or decremental).
: The main endpoint is the difference between the recruited lung volume measured by nitrogen washin-washout method at the end of each PEEP level (5th minute) with the basal value measured at the beginning of the protocol, between decremental and incremental stepwise PEEP titration
The last minute of each Peep Step
Secondary Outcomes (12)
Homogeneity of pulmonary aeration
The last minute of each Peep Step
Homogeneity of pulmonary aeration
The last minute of each Peep Step
Regional impedance variation
Measurement during the last minute of each PEEP step
Atelectrauma
Measurement during the last minute of each PEEP step
Lung volume variations
Measurement during the last minute of each PEEP step
- +7 more secondary outcomes
Study Arms (2)
Decremental PEEP titration following an ARM
ACTIVE COMPARATORPEEP will be titrated in a stepwise decremental fashion following a standardized alveolar recruitment maneuver (ARM). The ARM is a progressive increase of intra-thoracic pressure (pressure controlled mode), with a constant driving pressure of 10 cmH2O and PEEP steps (10-15-20-25-30-35 and 40 cmH2O), reaching a maximum pressure of 50 cmH2O, allowing full recruitment. PEEP steps will be conducted every 2 cmH2O (from 20 to 6 cmH2O), every 5 minutes.
Incremental PEEP titration without any previous ARM
ACTIVE COMPARATORPEEP will be titrated in a stepwise incremental fashion without any previous alveolar recruitment maneuver (ARM). PEEP steps will be conducted every 2 cmH2O (from 6 to 20 cmH2O), every 5 minutes.
Interventions
End expiratory lung volume and lung aeration measurements will be conducted using electrical impedance tomography and nitrogen washin-washout method. Measurements will be conducted during the last minute of each step.
End expiratory lung volume and lung aeration measurements will be conducted using electrical impedance tomography and nitrogen washin-washout method. Measurements will be conducted during the last minute of each step.
Eligibility Criteria
You may qualify if:
- Patient over 18 years of age
- ICU patients with healthy lungs or lungs with Acute Respiratory Distress Syndrome (according to Berlin criteria) under mechanically invasive controlled ventilation (intubation or tracheotomy) in the early phase of admission (\< 12h)
- Patient deeply sedated (BIS between 30 and 50) and possibly under neuromuscular blocking agents (TOF \< 2/4 at the orbicular) in case of inspiratory efforts
- Patient hemodynamically stable with an optimized volemia using a monitoring system (see protocol).
- Consent to participate
- Patient benefiting from a Social Security Insurance
You may not qualify if:
- Refusal to participate to the proposed study
- Obese patient with BMI ≥ 35 kg.cm-2
- Significant hemodynamic instability defined as \> 20% increase in catecholamine doses during the last hour, despite optimization of blood volume according to a pre-established protocol
- Contraindication to the use of the electro-impedance tomography technique
- Thoracic lesions
- Chest bandages
- Pace-maker/Implantable defibrillator
- Contraindication to the performance of an alveolar recruitment maneuver
- Major Emphysema
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU
Clermont-Ferrand, France
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Godet
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Statistical analysis will be conducted by an independant statistician not involved in data collection
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2020
First Posted
August 7, 2020
Study Start
September 12, 2019
Primary Completion
September 12, 2021
Study Completion
October 31, 2021
Last Updated
August 25, 2021
Record last verified: 2021-08